Alkem Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Alkem Laboratories	Aurobindo Pharma	Glenmark Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	187.0 .	876.0 .	13.0 .
Number of ANDA's Approved By USFDA	163.0 .	742.0 .	25.0 .
Number of ANDA's Filed in Europe	18.0	n/a	n/a
Number of ANDA's Approved in Europe	12.0	n/a	n/a
Number of ANDA's Filed in Australia	42.0	n/a	n/a
Number of ANDA's Approved by Australia	32.0	n/a	n/a
Domestic Sales Growth - YoY	9.9 %	n/a	18.9 %
R&D as a % of Total Sales	3.3 %	5.0 %	7.3 %
Financials
5 yr Average ROE	17.38 %	12.72 %	3.99 %
5yr average Equity Multiplier	1.39	1.46	1.78
5yr Average Asset Turnover Ratio	0.86	0.68	0.8
5yr Avg Net Profit Margin	14.54 %	12.5 %	2.85 %
Price to Book	4.84	1.9	5.88
P/E	27.24	19.13	52.9
5yr Avg Cash Conversion Cycle	-61.46 Days	-46.37 Days	-150.94 Days
Inventory Days	56.11 Days	59.62 Days	32.28 Days
Days Receivable	44.62 Days	30.33 Days	32.34 Days
Days Payable	122.42 Days	121.28 Days	201.14 Days
5yr Average Interest Coverage Ratio	24.48	43.54	4.25
5yr Avg ROCE	22.76 %	15.27 %	17.54 %
5yr Avg Operating Profit Margin	18.44 %	19.22 %	15.96 %
5 yr average Debt to Equity	0.18	0.19	0.38
5yr CAGR Net Profit	6.44 %	-8.16 %	1.54 %
5yr Average Return on Assets	12.47 %	8.64 %	2.09 %
Shareholdings
Promoter Holding	51.2 %	51.82 %	46.65 %
Share Pledged by Promoters	0.0	17.5 %	0.0
Change in Promoter Holding (3 Yrs)	-5.96 %	-0.01 %	0.0
Change in Mutual Fund Holding (3 Yrs)	6.0 %	12.02 %	12.22 %

Business

	Alkem Laboratories	Aurobindo Pharma	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 API 0 Formulations 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Formulations 88.36 Pharmaceutical 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 Active Pharmaceutical Ingredient (API) 11.64	Product Wise Break-Up Formulations 0 Pharmaceutical 0 Branded Generics 60.46 Formulations 39.54 API 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti-Infective 33.8 Gastro Intestinal 21.2 Vitamins / Minerals / Nutrients 12.0 Pain Management 10.1 Anti - Diabetes 5.0 Gynecology 4.1 Central Nervous System (CNS) 3.7 Respiratory 3.0 Derma 2.4 Cardiac Science 2.3 Others 2.4	-	-
Location Wise Break-Up	Location Wise Break-Up India 69.13 USA 29.72 Europe 0 Rest of the World 0 Latin America 0 North America 0 Others 1.15	Location Wise Break-Up Latin America 0 Rest of the World 17.0 USA 44.3 Europe 29.7 India 9.0 North America 0	Location Wise Break-Up Latin America 0 Rest of the World 10.91 USA 0 Europe 12.36 India 2.73 North America 73.99 Others 0.01
Asset Break-Up	Asset Break-Up India 70.19 USA 28.27 Europe 0 Rest of the World 0 Latin America 0 North America 0 Others 1.54	Asset Break-Up Latin America 0 Rest of the World 0 USA 18.21 Europe 7.85 India 65.14 North America 0 Others 8.8	Asset Break-Up Latin America 0 Rest of the World 4.94 USA 0 Europe 3.09 India 49.4 North America 42.56 Others 0.01

Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE